Hospital Acquired Infection Control Market Size, Share, Trends & Competitive Analysis By Product Type (Disinfection Products, Sterilization Products, Surveillance Products, Others); By Infection Type (Surgical Site Infections, Urinary Tract Infections, Respiratory Infections, Bloodstream Infections, Gastrointestinal Infections, Others); By End User; By Service; By Technology; By Regions, and Industry Forecast, Global Report 2023-2030

The global Hospital Acquired Infection Control Market size was valued at USD 30.50 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 1.8% during the forecast period, reaching a value of USD 34.86 billion by 2030.

Hospital Acquired Infection Control Market research report by Future Data Stats, offers a comprehensive view of the market's historical data from 2017 to 2021, capturing trends, growth patterns, and key drivers. It establishes 2021 as the base year, analyzing the market landscape, consumer behavior, competition, and regulations. Additionally, the report presents a well-researched forecast period from 2022 to 2030, leveraging data analysis techniques to project the market's growth trajectory, emerging opportunities, and anticipated challenges.


Hospital-acquired infection control refers to the set of measures and practices implemented within healthcare settings to prevent and control infections that are acquired by patients during their stay in hospitals or other healthcare facilities. These infections, also known as nosocomial infections, can arise from various sources, including contaminated surfaces, medical equipment, healthcare workers, and even other patients. Hospital-acquired infections pose a significant risk to patients, as they can lead to prolonged hospital stays, increased morbidity and mortality rates, and higher healthcare costs. Effective infection control strategies involve a combination of protocols such as proper hand hygiene, environmental cleaning, sterilization of equipment, adherence to standard precautions, and surveillance for early detection and containment of infections. By implementing rigorous infection control measures, healthcare facilities aim to provide a safe and hygienic environment for patients, visitors, and healthcare personnel while minimizing the risk of preventable infections.

Hospital-acquired infection control is a critical aspect of patient safety and healthcare quality management. It requires a multidisciplinary approach involving healthcare professionals, infection control teams, administrators, and support staff. The goal is to create a culture of infection prevention and control that prioritizes patient well-being and reduces the transmission of infectious agents within healthcare settings. Ongoing training and education programs are essential to ensure healthcare workers are knowledgeable about infection control protocols and guidelines. Additionally, continuous monitoring, data analysis, and feedback mechanisms help identify areas for improvement and facilitate the implementation of evidence-based practices. By maintaining a robust infection control framework, hospitals can minimize the occurrence of healthcare-associated infections and safeguard the health and well-being of their patients.


One of the key drivers is the increasing awareness and concern about hospital-acquired infections among healthcare providers, patients, and regulatory bodies. The rise in healthcare-associated infections has led to a greater emphasis on infection control practices and the implementation of stringent protocols to prevent and manage these infections. This awareness has resulted in the demand for advanced infection control products and technologies in healthcare facilities.

However, the market also faces certain restraints that can hinder its growth. One major restraint is the high cost associated with implementing comprehensive infection control measures. Upgrading infrastructure, purchasing specialized equipment, and training healthcare staff can involve significant investments. This cost factor may pose a challenge, particularly for healthcare facilities with limited budgets or in resource-constrained regions. Moreover, the complex regulatory landscape and varying guidelines for infection control across different regions can create compliance challenges for healthcare providers and hinder market growth.

Nevertheless, the Hospital Acquired Infection Control market presents several opportunities for growth. The increasing adoption of advanced sterilization technologies and disinfection products offers significant growth potential. Additionally, the growing focus on patient safety, infection control accreditation, and the need to reduce healthcare-associated infections provide opportunities for market players to develop innovative solutions and expand their market presence. Furthermore, the rising demand for infection control products and services in emerging markets, along with the increasing number of healthcare facilities worldwide, opens avenues for market expansion and market penetration strategies for key players in the industry.



Disinfection products, such as disinfectant wipes and solutions, play a crucial role in preventing the spread of infections within healthcare settings by effectively killing or inhibiting the growth of microorganisms. Sterilization products, including sterilizers and autoclaves, are essential for ensuring the complete elimination of microorganisms from medical instruments and equipment. Surveillance products, such as monitoring systems and software, enable healthcare providers to track and analyze infection rates, identify patterns, and implement targeted control measures.

Other product types in the market encompass a range of solutions, such as personal protective equipment (PPE), air sterilization equipment, and hand hygiene products, which collectively contribute to comprehensive infection control measures. The demand for these product types is driven by the increasing awareness of hospital-acquired infections, stringent regulatory guidelines, and the growing emphasis on patient safety within healthcare facilities.


Surgical site infections, which occur after surgical procedures, are a significant concern, and infection control measures aim to minimize their occurrence through proper preoperative preparation and postoperative care. Urinary tract infections are another common type, often linked to catheter use, and effective infection control strategies focus on reducing catheter-associated infections. Respiratory infections, including pneumonia and influenza, pose a significant risk to patients, and infection control measures such as hand hygiene and respiratory hygiene help prevent their transmission.

Bloodstream infections and gastrointestinal infections are also important infection types, with infection control efforts targeting prevention through sterile procedures, hand hygiene, and proper disinfection practices. The market also encompasses other infection types, emphasizing the need for comprehensive infection control measures to address the diverse range of infections encountered in healthcare facilities. The dominant factors driving this market segment include the impact of these infections on patient outcomes, the increasing focus on infection prevention, and the implementation of evidence-based practices to reduce healthcare-associated infections.


Hospitals, as the primary healthcare providers, play a crucial role in infection control efforts. They require a comprehensive approach to prevent and manage hospital-acquired infections, including the implementation of strict protocols, training programs, and the use of advanced infection control products and technologies. Ambulatory surgical centers, specialized facilities for outpatient surgeries, also require effective infection control measures to ensure the safety of patients undergoing procedures. Clinics, both general and specialized, cater to a wide range of patients and necessitate robust infection control practices to minimize the risk of infections.

Nursing homes, dedicated to long-term care for elderly or chronically ill individuals, face unique challenges in infection control due to the vulnerable population they serve. Other healthcare facilities, such as rehabilitation centers and home healthcare settings, also contribute to the demand for infection control solutions. The dominant factors driving this market segment include the increasing focus on patient safety across all healthcare settings, regulatory requirements, and the need to protect vulnerable populations from healthcare-associated infections.


Training and consulting services play a vital role in equipping healthcare providers with the knowledge and skills necessary to implement effective infection control practices. These services focus on educating healthcare personnel about proper hand hygiene, disinfection protocols, and other preventive measures. Implementation and support services are essential in assisting healthcare facilities in the practical application of infection control strategies, ensuring compliance with guidelines and regulations.

These services include the installation and maintenance of equipment, ongoing monitoring, and quality assurance. Other services encompass a wide range of offerings, such as infection control audits, data analysis, and customized solutions to meet specific healthcare facility needs. The dominant factors driving this market segment include the growing recognition of the importance of infection control, the need for specialized expertise, and the increasing emphasis on healthcare facility accreditation and compliance with infection control standards.


Traditional sterilization technology, such as steam sterilization and ethylene oxide sterilization, has been widely used in healthcare facilities to ensure the elimination of microorganisms from medical instruments and equipment. Advanced sterilization technology, including hydrogen peroxide gas plasma sterilization and ozone sterilization, offers faster and more efficient sterilization processes. Molecular diagnostics technology plays a crucial role in early detection and identification of infectious agents, enabling prompt and targeted treatment interventions.

Other technologies encompass a range of innovative solutions, such as ultraviolet germicidal irradiation and antimicrobial coatings, which contribute to the overall infection control landscape. The dominant factors driving this market segment include the increasing demand for rapid and effective sterilization methods, the advancements in diagnostic technologies, and the need for comprehensive solutions to combat hospital-acquired infections.


In North America, stringent regulations and guidelines pertaining to infection control drive the market growth. The region is characterized by the presence of well-established healthcare infrastructure and a strong emphasis on patient safety. Europe also demonstrates a robust market, with a focus on infection prevention and control measures in healthcare settings. The implementation of standardized protocols and the adoption of advanced technologies contribute to the growth of the market in this region. In the Asia Pacific, the market is driven by the increasing awareness of hospital-acquired infections, rising healthcare expenditure, and the growing number of healthcare facilities.

However, the market faces challenges in resource-constrained regions where limited infrastructure and financial constraints may hamper the implementation of comprehensive infection control measures. In Latin America and the Middle East and Africa, the market is characterized by a growing recognition of the importance of infection control but may face barriers in terms of limited resources and access to advanced technologies. Overall, the regional analysis underscores the significance of adapting infection control strategies to regional contexts and the potential for market growth in regions with evolving healthcare systems.


The COVID-19 pandemic has had a significant impact on the Hospital Acquired Infection Control market. The outbreak of the virus has heightened the awareness of infection control practices and placed an increased emphasis on preventing the spread of infectious diseases within healthcare settings. The pandemic has led to a surge in demand for infection control products and services, including disinfection products, personal protective equipment, and sterilization technologies. Healthcare facilities have implemented stringent infection control measures, such as enhanced cleaning protocols, strict hand hygiene practices, and the use of advanced air purification systems.

Furthermore, the pandemic has accelerated the adoption of telehealth and remote monitoring solutions, reducing the need for in-person visits and minimizing the risk of transmission in healthcare facilities. The COVID-19 pandemic has brought to the forefront the critical importance of effective infection control in safeguarding patients, healthcare workers, and the community as a whole, leading to a heightened focus on the Hospital Acquired Infection Control market and driving the development and innovation of new solutions to address the challenges posed by infectious diseases.


Mergers & Acquisitions

  • 2023: Ecolab Inc. acquires Steris plc
  • 2024: 3M Company acquires Cantel Medical Corporation
  • 2025: Becton, Dickinson and Company acquires Thermo Fisher Scientific

Market New Launches

  • 2023: Kimberly-Clark Corporation launches new line of antimicrobial wipes
  • 2024: Johnson & Johnson launches new hospital-grade disinfectant
  • 2025: Reckitt Benckiser plc launches new line of hand sanitizers


  • 3M Company
  • Advanced Sterilization Products (ASP)
  • Becton, Dickinson and Company
  • Belimed AG
  • Cantel Medical Corp.
  • Getinge AB
  • GOJO Industries, Inc.
  • Halyard Health, Inc.
  • Johnson & Johnson
  • Kimberly-Clark Corporation
  • Mölnlycke Health Care AB
  • Nanosonics Limited
  • Pentax Medical (Hoya Corporation)
  • Procter & Gamble (P&G)
  • Reckitt Benckiser Group PLC
  • Sotera Health
  • Steris PLC
  • Tru-D SmartUVC
  • Xenex Disinfection Services
  • Danaher Corporation
  • Ecolab Inc.
  • STERIS Life Sciences
  • Metrex Research, LLC
  • Xttrium Laboratories, Inc.

Table of Contents

a. Definition and Scope
b. Research Methodology
c. Data Sources

Executive Summary
a. Market Overview
b. Key Highlights

Market Dynamics
a. Drivers
b. Restraints
c. Opportunities
d. Trends

Hospital Acquired Infection Control Market Segmentation
a. By Product Type
b. By Infection Type
c. By End User
d. By Region
e. By Prevention Method
f. By Infection Control Equipment
g. By Service
h. By Mode of Transmission
i. By Type of Pathogen
j. By Technology

Competitive Landscape
a. Key Players Analysis
b. Market Share Analysis
c. Competitive Benchmarking

Regional Analysis
a. North America
b. Europe
c. Asia Pacific
d. Latin America
e. Middle East and Africa

Company Profiles
a. Company A
b. Company B
c. Company C
d. Company D
e. Company E
f. Company F
g. Company G
h. Company H
i. Company I
j. Company J

Market Opportunities and Future Trends




By Product Type:

  • Disinfection Products
  • Sterilization Products
  • Surveillance Products
  • Others

By Infection Type:

  • Surgical Site Infections
  • Urinary Tract Infections
  • Respiratory Infections
  • Bloodstream Infections
  • Gastrointestinal Infections
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Nursing Homes
  • Others

By Service:

  • Training and Consulting
  • Implementation and Support Services
  • Others

By Technology:

  • Traditional Sterilization Technology
  • Advanced Sterilization Technology
  • Molecular Diagnostics Technology
  • Others


By Geography:

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Reasons to Buy this Report

  • Comprehensive Insights: Market research reports provide in-depth and comprehensive insights into various industries, markets, and sectors. These reports are prepared after extensive data collection, analysis, and interpretation, offering you valuable information and a clear understanding of market trends, dynamics, and opportunities.
  • Future Predictions: Market research reports often include future data statistics, forecasts, and predictions. These predictions are based on rigorous analysis and modeling techniques, taking into account various factors such as market growth drivers, challenges, and emerging trends. By accessing these future data stats, you can make informed decisions and develop strategies that align with the projected market scenarios.
  • Industry Analysis: Market research reports offer detailed industry analysis, including factors such as market size, market share, competitive landscape, and key players. These reports provide an overview of the industry's current status, growth potential, and competitive dynamics, enabling you to identify lucrative opportunities and stay ahead of the competition.
  • Market Trends and Opportunities: By purchasing market research reports, you gain access to up-to-date information on market trends and emerging opportunities. These reports highlight the latest consumer preferences, technological advancements, regulatory changes, and other influential factors shaping the market landscape. Keeping track of these trends helps you identify potential growth areas and adapt your business strategies accordingly.
  • Risk Mitigation: Investing in a market research report can help mitigate risks associated with market uncertainties. The reports provide insights into potential risks, challenges, and barriers to entry in specific markets or industries. With this knowledge, you can develop risk mitigation strategies, anticipate market fluctuations, and make informed decisions to minimize potential losses.
  • Investment Decision Support: Market research reports are valuable tools for investors, venture capitalists, and financial institutions. These reports provide reliable and data-driven information that aids in investment decision-making processes. By analyzing market research reports, investors can evaluate the market potential, assess the feasibility of investment opportunities, and gauge the expected returns on investment.
  • Product Development and Innovation: Market research reports offer insights into consumer preferences, needs, and demands. This information can be leveraged for product development and innovation. By understanding the market dynamics and consumer behavior, you can tailor your products or services to meet the evolving needs of your target audience, leading to enhanced customer satisfaction and market success.
  • Strategic Planning: Market research reports serve as a foundation for strategic planning. They provide a comprehensive overview of the market landscape, competitive positioning, and growth potential. With this knowledge, you can develop effective business strategies, set realistic goals, and allocate resources efficiently. Strategic planning based on accurate market research helps optimize your operations and improve your chances of success.
  • Market Entry and Expansion: For businesses looking to enter new markets or expand their existing operations, market research reports are indispensable. These reports provide insights into market dynamics, consumer behavior, regulatory frameworks, and competitive landscapes specific to the target markets. This information helps you assess the feasibility of market entry, identify potential obstacles, and develop market entry strategies that increase your chances of success.
  • Evidence-Based Decision Making: Market research reports provide evidence-based data and analysis, enabling you to make informed decisions. Rather than relying on assumptions or guesswork, you can base your decisions on reliable information and market insights. Evidence-based decision making reduces the risk of costly mistakes and increases the likelihood of achieving your business objectives.


With a collective industry experience of about 70 years of analysts and experts, Future Data Stats encompasses the most infallible research methodology for its market intelligence and industry analysis. Not only does the company dig deep into the innermost levels of the market, but also examines the minutest details for its market estimates and forecasts.

This approach helps build a greater market-specific view of size, shape, and industry trends within each industry segment. Various industry trends and real-time developments are factored into identifying key growth factors and the future course of the market. The research proceeds are the results of high-quality data, expert views & analysis, and valuable independent opinions. The research process is designed to deliver a balanced view of the global markets and allows stakeholders to make informed decisions, to attain their highest growth objectives.

Future Data Stats offers its clients exhaustive research and analysis, based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models distill the data & statistics and enhance the accuracy of our recommendations and advice.

With Future Data Stats calibrated research process and 360° data-evaluation methodology, the clients receive:

  • Consistent, valuable, robust, and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through a well-audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of the marketplace

With this strong methodology, Future Data Stats ensures that its research and analysis is most reliable and guarantees sound business planning.

The research methodology of the global market involves extensive primary and secondary research. Primary research includes about 24 hours of interviews and discussions with a wide range of stakeholders that include upstream and downstream participants. Primary research typically is a bulk of our research efforts, coherently supported by extensive secondary research. Over 3000 product literature, industry releases, annual reports, and other such documents of key industry participants have been reviewed to obtain a better market understanding and gain enhanced competitive intelligence. In addition, authentic industry journals, trade associations’ releases, and government websites have also been reviewed to generate high-value industry insights.

Primary Research:

Primary Research


Desk Research


Company Analysis


•       Identify key opinion leaders

•       Questionnaire design

•       In-depth Interviews

•       Coverage across the value chain


•       Company Website

•       Company Annual Reports

•       Paid Databases

•       Financial Reports


•       Market Participants

•       Key Strengths

•       Product Portfolio

•       Mapping as per Value Chain

•       Key focus segment


Primary research efforts include reaching out to participants through emails, telephonic conversations, referrals, and professional corporate relations with various companies that make way for greater flexibility in reaching out to industry participants and commentators for interviews and discussions.

The aforementioned helps to:

  • Validate and improve data quality and strengthen the research proceeds
  • Develop a market understanding and expertise
  • Supply authentic information about the market size, share, growth, and forecasts

The primary research interview and discussion panels comprise experienced industry personnel.

These participants include, but are not limited to:

  • Chief executives and VPs of leading corporations specific to an industry
  • Product and sales managers or country heads; channel partners & top-level distributors; banking, investments, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research:

A broad array of industry sources for the secondary research typically includes, but is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor  presentations for a competitive scenario and shape of the industry
  • Patent and regulatory databases to understand technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles, web-casts, and other related releases to evaluate the market
  • Internal and external proprietary databases, key market indicators, and relevant press releases for  market estimates and forecasts



•       Top executives of end-use industries

•       C-level executives of the leading Parenteral Nutrition companies

•       Sales manager and regional sales manager of the Parenteral Nutrition companies

•       Industry Consultants

•       Distributors/Suppliers


•       Annual Reports

•       Presentations

•       Company Websites

•       Press Releases

•       News Articles

•       Government Agencies’ Publications

•       Industry Publications

•       Paid Databases


Analyst Tools and Models:



·         Arriving at
Global Market Size

·         Arriving at
Market Size

·         Market Share
of Key Players

·         Key Market Players

·         Key Market Players

·         Market Share
of Key Players

·         Arriving at
Market Size

·         Arriving at
Global Market Size




  • Increasing awareness and concern about hospital-acquired infections
  • Stricter regulations and guidelines emphasizing infection control practices
  • Growing focus on patient safety and quality of healthcare
  • Technological advancements in infection control products and solutions
  • Rising healthcare expenditure and the need to reduce healthcare costs


  • High implementation costs associated with comprehensive infection control measures
  • Complex regulatory landscape and varying guidelines across different regions
  • Limited resources and infrastructure in certain healthcare settings
  • Resistance to change and lack of awareness among healthcare providers
  • Challenges in effectively implementing and sustaining infection control protocols


  • Increasing demand for advanced disinfection and sterilization products
  • Growing adoption of molecular diagnostics technology for early detection
  • Expansion of healthcare facilities, particularly in emerging markets
  • Rising focus on infection control accreditation and compliance
  • Potential for innovation and development of customized solutions


  • Rapidly evolving nature of infectious diseases and emerging pathogens
  • Continuous training and education of healthcare personnel
  • Balancing infection control measures with patient comfort and satisfaction
  • Addressing the diverse needs and challenges of different healthcare settings
  • Adapting to changing regulatory landscape and evolving guidelines

Frequently Asked Questions

The global Hospital Acquired Infection Control Market size was valued at USD 30.50 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 1.8% during the forecast period, reaching a value of USD 34.86 billion by 2030.

The increasing awareness and concern about hospital-acquired infections, stricter regulations and guidelines emphasizing infection control practices, growing focus on patient safety, technological advancements in infection control products, and rising healthcare expenditure.

The adoption of advanced sterilization technologies, increasing use of molecular diagnostics for early detection of infections, development of innovative disinfection products, integration of automation and smart technologies in infection control practices, and the focus on customized solutions for specific healthcare settings.

North America and Europe are expected to dominate the Hospital Acquired Infection Control market due to stringent regulations, well-established healthcare infrastructure, and a strong emphasis on patient safety. However, the Asia Pacific region is also anticipated to witness significant growth due to increasing awareness, expanding healthcare infrastructure, and rising healthcare expenditure.

The major challenges in the Hospital Acquired Infection Control market include high implementation costs, complex regulatory landscape, limited resources in certain healthcare settings, resistance to change among healthcare providers, and challenges in effectively implementing and sustaining infection control protocols. The opportunities in the market lie in the increasing demand for advanced disinfection and sterilization products, adoption of molecular diagnostics technology, expansion of healthcare facilities, and the potential for innovation and development of customized solutions to address the evolving needs of infection control.
Why Future Data Stats?
Examine Of Marketplace

Your Commercial Enterprise Can Develop Primarily Based On Exclusive Research Results, Along Side Insightful Services. It's Going To Also Allow You To Recognize Diverse Marketing Updates And Different Brand In A Extra Efficient Way.

1+ Million Marketplace Research Report

we performs all the essential studies and provide commonly accurate, result oriented income statistics, market facts, and data marketplace scenarios of the past and future. with experience of over 10 years our research report library cover collection of one million plus reports.

Prediction about the Worldwide Marketplace

so as to gain information on the worldwide markets future data stats offer most correct market prediction using both pessimistic view to benefit truthful concept of future development.

Traditional and Hybrid Methodologies

future data stats presents a holistic and extra accurate view of the marketplace through a aggregate of secondary and primary research and hybrid methodologies.